Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation-Reference-Cited by-同舟云学术

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Published:2016-03-07 Issue:3 Volume:173 Page:444-455
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mehta Rohtesh S.¹,Saliba Rima M.¹,Chen Julianne¹,Rondon Gabriela¹,Hammerstrom Aimee E.¹,Alousi Amin¹,Qazilbash Muzaffar¹,Bashir Qaiser¹,Ahmed Sairah¹,Popat Uday¹,Hosing Chitra¹,Khouri Issa¹,Shpall Elizabeth J.¹,Champlin Richard E.¹,Ciurea Stefan O.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13977/fullpdf

Reference42 articles.

1. Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life;Alatrash;Biology of Blood and Marrow Transplantation,2011

2. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors;Ayuk;Experimental Hematology,2008

3. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001